Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Management appointment

8 Aug 2011 12:00

RNS Number : 9338L
Microsaic Systems plc
08 August 2011
 

Microsaic Systems plc

 ("Microsaic" or the "Company")

 

APPOINTMENT OF SAMANTHA DUNNAGE TO LEAD DIRECT PRODUCT SALES

 

8 August 2011: Microsaic Systems plc (AIM: MSYS), the developer of chip-based scientific instruments, today announces that Samantha Dunnage has joined to lead the Company's marketing and direct sales. Samantha joins Microsaic Systems from Uniqsis Ltd where she successfully launched and grew sales of innovative solutions to customers from the pharmaceutical industry across the USA and Europe.

 

Microsaic is the first and only company to have successfully miniaturised mass spectrometry ("MS") through the development of its patented chip-based technologies (ionchip®, spraychip® and vac-chip®). The Company's first product, the Microsaic 3500 MiD®, was launched in January 2011. It is a desktop MS system that is smaller, lighter, more energy efficient and cheaper to run than legacy conventional MS systems.

 

Mass spectrometry is widely accepted as a 'gold-standard' method for identifying chemicals. As a result, this technique is used routinely by chemists across a range of sectors including government, energy, utilities, pharmaceuticals, environmental, food and drink, healthcare and industrial chemicals.

 

Commenting on today's appointment, Alan Finlay, Chief Executive of Microsaic Systems plc, said:

 

"We are delighted to welcome Samantha to the team. These past months have seen Microsaic Systems make good commercial and technical progress including successful product demonstrations to end-users from a broad range of markets, a growing number of engagements with sales channels and OEM partners and a resounding reception for our products and technology at ASMS 2011, the premier trade fair for our industry. In her role, Samantha will be capitalising on the interest generated so far to accelerate product introduction."

 

Contacts

Microsaic Systems

Alan Finlay, CEO

Via Citigate Dewe Rogerson

Numis Securities Limited

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

 

+44 (0)20 7260 1000

Citigate Dewe Rogerson

Chris Gardner, Mark Swallow

 

+44 (0)20 7282 2995/2948

 

 

About Microsaic Systems

 

Microsaic Systems develops micro-engineered scientific instruments for the identification of chemicals in liquids, gases and solids. Microsaic's technologies are based on the gold-standard technique of mass spectrometry (MS), which is currently based on large and expensive systems.

 

Microsaic is the first and only company to have successfully miniaturised MS onto patented chip-based technologies (ionchip®, spraychip® and vac-chip®) to create instruments that retain the speed and sensitivity of MS but are smaller, lighter, more energy efficient and cheaper to run than conventional MS systems.

 

MS technology is used across multiple sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3.3 billion in 2010.

 

Microsaic Systems was established in 2001 by a team including founders from Imperial College London and was admitted to AIM in April 2011 under the ticker MSYS.

 

www.microsaic.com 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAEPPESPFEFF
Date   Source Headline
13th Feb 20257:00 amRNSChange of Name Effective
6th Feb 20257:00 amRNSBoard Changes
14th Jan 20257:00 amRNSOperational Update
12th Dec 20247:00 amRNSResult of AGM, Update & Change of Name
26th Nov 20247:00 amRNSOperational Update
14th Nov 20247:00 amRNSNotice of AGM
12th Nov 20247:30 amRNSRestoration - Microsaic Systems plc
12th Nov 20247:26 amRNSRestoration
12th Nov 20247:00 amRNSHalf-year Report
5th Nov 20243:54 pmRNSUpdate on Publication of Interim Results
11th Oct 20247:00 amRNSFinal Results
24th Jul 20247:00 amRNSUpdate re. Publication of Annual Report & Accounts
1st Jul 20247:30 amRNSSuspension - Microsaic Systems plc
25th Jun 20248:06 amRNSCompany Update
19th Jun 20247:00 amRNSPublication of Annual Report & Accounts
14th Jun 20247:00 amRNSNew Product Development
2nd May 20247:00 amRNSCompany Update
27th Mar 20248:49 amRNSCompany Update
16th Feb 20247:00 amRNSCompany Update
25th Jan 20247:00 amRNSCompletion of Acquisition
23rd Jan 20241:30 pmRNSHolding(s) in Company
18th Jan 20246:15 pmRNSHolding(s) in Company
18th Jan 20243:15 pmRNSHolding(s) in Company
18th Jan 202412:00 pmRNSHolding(s) in Company
18th Jan 202410:05 amRNSHolding(s) in Company
16th Jan 20247:30 amRNSRestoration - Microsaic Systems PLC
16th Jan 20247:00 amRNSHalf-year Report
16th Jan 20247:00 amRNSFinal Results
16th Jan 20247:00 amRNSRestoration & Update
15th Jan 20243:45 pmRNSConditional Placing
12th Jan 20244:15 pmRNSAcquisition, Update & Change of Registered Office
4th Jan 20247:00 amRNSUpdate
29th Dec 202311:41 amRNSResult of General Meeting
22nd Dec 20231:27 pmRNSAcquisition & Fundraise Update, Revised Timetable
20th Dec 20233:03 pmRNSUpdate on Prospective Acquisition, Fundraise & GM
20th Dec 202312:30 pmRNSUpdate on Prospective Acquisition, Fundraise & GM
14th Dec 20237:00 amRNSUpdate on Financing, GM & Prospective Acquisition
4th Dec 20237:00 amRNSPublication of Circular and Notice of GM
13th Nov 20238:42 amRNSFunding Update
6th Nov 20237:00 amRNSFunding & Operational Update, Intention to Delist
3rd Nov 20231:32 pmRNSFunding & Operational Update, Intention to Delist
25th Sep 20237:00 amRNSUpdate and Directorate change
3rd Jul 20237:30 amRNSSuspension - Microsaic Systems PLC
29th Jun 20234:00 pmRNSAnnual Financial Report
26th Jun 20237:15 amRNSDeepVerge: debtor update
15th May 20237:15 amRNSAudit update
18th Apr 20237:59 amRNSDeepVerge plc debtor
13th Mar 202310:10 amRNSHolding(s) in Company
28th Dec 20229:25 amRNSHolding(s) in Company
24th Nov 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.